-
Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019
-
View Affiliations Hide AffiliationsDamon Getmandamon.getman hologic.com
-
View Citation Hide Citation
Citation style for this article: . Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019. Euro Surveill. 2020;25(5):pii=2000038. https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000038 Received: 16 Jan 2020; Accepted: 05 Feb 2020
Abstract
The Finnish new variant of Chlamydia trachomatis (FI-nvCT) is escaping diagnostics in Finland, Norway and Sweden. We have developed and validated an Aptima-format nucleic acid amplification test (NAAT) designed specifically to detect the FI-nvCT. This NAAT has high sensitivity (100%) and specificity (100%) for the FI-nvCT strain, enabling further investigation of the geographic distribution, prevalence and transmission of this diagnostic-escape mutant in screening populations in Europe.
Full text loading...